PMID- 35218021 OWN - NLM STAT- MEDLINE DCOM- 20221018 LR - 20221208 IS - 1531-4995 (Electronic) IS - 0023-852X (Linking) VI - 132 IP - 11 DP - 2022 Nov TI - Association Between Alcohol Dehydrogenase Polymorphisms and the Recurrence of Laryngeal Carcinoma. PG - 2169-2176 LID - 10.1002/lary.30083 [doi] AB - OBJECTIVES: Alcohol consumption is closely associated with prognosis for laryngeal squamous cell carcinoma (LSCC) patients. As key enzymes in ethanol metabolism, proteins in the alcohol dehydrogenase (ADH) family make for valuable targets to establish a novel predictive nomogram model. This study attempts to do so by focusing on the single nucleotide polymorphisms (SNPs) of ADH1B and ADH1C in LSCC. METHODS: Sixty eight LSCC patients that were followed up for more than 10 years were retrospectively analyzed. Endpoints of the current study included disease-free survival and overall survival. Survival analyses were performed using the Kaplan-Meier method and evaluated by log-rank test. The prognostic value of eight ADH1B SNPs and three ADH1C SNPs were evaluated using univariate and multivariate Cox regression analyses. A nomogram model for disease-free survival was established and evaluated using the receiver operating characteristic curve, the C-index, and a calibration plot. RESULTS: Significant association was exhibited between rs17033 (p < 0.001) and rs1229984 (p = 0.002) with an increase in LSCC recurrence rate on Kaplan-Meier curves. Multivariate logistic regression analysis revealed that the rs17033 polymorphism of ADH1B was independently associated with an increased risk of LSCC recurrence (HR = 3.325, 95% CI = 1.684-6.566, p = 0.001). Based on these findings, a prognostic nomogram of LSCC patients involving ADH1B rs17033 was constructed. CONCLUSION: This study has demonstrated an independent association between ADH1B gene variants and the recurrence of LSCC. A nomogram model based on rs17033 of ADH1B, age, T, and N stages were successfully developed for the first time to predict the probability of recurrence in LSCC patients. LEVEL OF EVIDENCE: 3 Retrospective cohort study Laryngoscope, 132:2169-2176, 2022. CI - (c) 2022 The American Laryngological, Rhinological and Otological Society, Inc. FAU - Huang, Hui-Ying AU - Huang HY AUID- ORCID: 0000-0002-5587-3576 AD - Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Lau, Hui-Ching AU - Lau HC AD - Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Ji, Meng-You AU - Ji MY AUID- ORCID: 0000-0002-1006-1670 AD - Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Hsueh, Chi-Yao AU - Hsueh CY AD - Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Zhang, Ming AU - Zhang M AUID- ORCID: 0000-0003-2909-8446 AD - Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220225 PL - United States TA - Laryngoscope JT - The Laryngoscope JID - 8607378 RN - 3K9958V90M (Ethanol) RN - EC 1.1.1.1 (Alcohol Dehydrogenase) SB - IM MH - Alcohol Dehydrogenase/genetics MH - Ethanol MH - *Head and Neck Neoplasms MH - Humans MH - *Laryngeal Neoplasms/pathology MH - Prognosis MH - Retrospective Studies MH - Squamous Cell Carcinoma of Head and Neck OTO - NOTNLM OT - ADH1B OT - SNP OT - laryngeal carcinoma OT - nomogram OT - polymorphism OT - prognosis EDAT- 2022/02/27 06:00 MHDA- 2022/10/19 06:00 CRDT- 2022/02/26 05:45 PHST- 2022/01/23 00:00 [revised] PHST- 2021/10/19 00:00 [received] PHST- 2022/02/14 00:00 [accepted] PHST- 2022/02/27 06:00 [pubmed] PHST- 2022/10/19 06:00 [medline] PHST- 2022/02/26 05:45 [entrez] AID - 10.1002/lary.30083 [doi] PST - ppublish SO - Laryngoscope. 2022 Nov;132(11):2169-2176. doi: 10.1002/lary.30083. Epub 2022 Feb 25.